Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: weight

Case Report: Tumor Treatment Unleashes Autoimmunity

Shuwei Wang, MD, Gulam A. Manji, MD, PhD, & Anca D. Askanase, MD  |  November 17, 2019

Immune checkpoint inhibitors (ICIs) targeting the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) or programmed cell death protein 1 (PD-1) axes have revolutionized therapy and improved survival in advanced cancers. However, these immune system modulators also lead to immune-related adverse events (IRAEs).1,2 In clinical trials, IRAEs mainly involved the gastrointestinal tract, skin, endocrine glands, liver and lung,…

Filed under:ConditionsMyositis Tagged with:CancerCheckpoint Inhibitorsdurvalumabendocrine diseasemyositis

A CT of the abdomen demonstrated numerous hypodense lesions present in both lobes of the liver, with the largest lesion measuring 2.0 x 3.1 cm.

Case Report: A Patient with Gout Develops Granulomatous Hepatitis

Raj Vachhani, MD, & Angelo L. Gaffo, MD, MSPH  |  November 16, 2019

Case Presentation A 45-year-old man with crystal-proven gout, poorly controlled diabetes and chronic kidney disease was lost to follow-up for six years and presented back to the VA clinic in the midst of a gout flare. He stated he had continued taking 100 mg of allopurinol daily, but his serum urate level was 13.8 mg/dL….

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:Allopurinolgranulomatous hepatitis

The 2019 ARP Awards of Distinction & ACR Masters

Carol Patton, with Keri Losavio  |  November 16, 2019

ATLANTA—At the 2019 ACR/ARP Annual Meeting in November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARP Merit Awards about their individual contributions to advancing rheumatology. You’ll also find a…

Filed under:Awards Tagged with:2019 ACR/ARP Annual MeetingAnnelle ReedAssociation of Rheumatology Professionals (ARP)Dana GuglielmoDr. Calvin R. Brown Jr.Dr. Carlos PinedaDr. Chester V. OddisDr. Fredrica E. SmithDr. Gerd R. BurmesterDr. Geri NeubergerDr. Grant W. CannonDr. Hani El-GabalawyDr. J. Lee NelsonDr. James N. JarvisDr. John D. ReveilleDr. John J. O’SheaDr. Jonathan S. CoblynDr. Jürgen BraunDr. Lee Stuart SimonDr. Linda Kay MyersDr. Michelle A. PetriDr. Nighat Mir AhmadDr. Ronald M. LaxerDr. Rosalind Ramsey-GoldmanDr. Rowland W. ChangDr. Sharad LakhanpalDr. Simon HelfgottDr. William F.C. RigbyHeather BenhamJoni DeanMichael LaValleyMonique GignacRobert Richardson

Rep. Schofield and Dr. Worthing listen to an audience member's question.

1 Person Can Make a Difference: The Importance of Advocacy

Keri Losavio  |  November 11, 2019

Your voice matters: That was the shared theme of presentations by Angus Worthing, MD, FACR, FACP, William F. Harvey, MD, MSc, FACR, and Georgia Rep. Kim Schofield (D-Atlanta, Dist. 60) in the session, Raise Your Voice! Advocacy Update from Government Affairs at the 2019 ACR/ARP Annual Meeting on Monday, Nov. 11.

Filed under:American College of RheumatologyLegislation & AdvocacyMeeting ReportsProfessional Topics Tagged with:2019 ACR/ARP Annual MeetingAdvocacyDr. Will HarveyDr. WorthingRepresentative Kim Schofield

2019 EULAR/ACR SLE Classification Criteria Offer Improved Sensitivity & Specificity

Susan Bernstein  |  November 6, 2019

The new EULAR/ACR classification criteria for SLE offer improved sensitivity and specificity, as well as more accurately reflect the current tests used to clinically diagnose SLE. A positive ANA test is obligatory…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:criteriaResearchsystemic lupus erythematosus (SLE)

Move Along: Insights Into Gastrointestinal Involvement in Systemic Sclerosis

Jason Liebowitz, MD, FACR  |  October 21, 2019

For patients with gastrointestinal (GI) manifestations of scleroderma, the effect on quality of life & longevity can be dramatic. But advances are being made in the diagnosis & treatment of these patients…

Filed under:ConditionsEULAR/OtherMeeting ReportsOther Rheumatic Conditions Tagged with:EULARgastrointestinalSystemic sclerosis

Study Says Mothers’ Cardiovascular Health Is Linked to Pregnancy Outcomes in Lupus

Ruth Jessen Hickman, MD  |  October 18, 2019

A recent study in The Journal of Rheumatology sheds light on the importance of preconceptional cardiovascular health in women with systemic lupus erythematosus. Although many questions remain, improved cardiovascular health measures seem to positively affect pregnancy outcomes, suggesting a potential role for preconception cardiovascular interventions.1 Women with lupus now have healthier pregnancies than in the…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:cardiovascularpregnancy

Researchers Seek the Best Methods to Maintain Remission in Vasculitis

Jason Liebowitz, MD, FACR  |  October 18, 2019

MADRID—During the 2019 European Congress of Rheumatology (EULAR), held June 12–15, speakers addressed the complexity of vasculitis in a Challenges in Clinical Practice session titled, How to Maintain Remission in Vasculitis. Although vasculitis appears in many varieties, one commonality exists among these related yet distinct conditions: When there is vital organ or systemic involvement, disease…

Filed under:ConditionsResearch RheumVasculitis Tagged with:EULARRemission

Lightspring / shutterstock.com

Why You Should Consider Adding a Dietitian to Your Team

Linda Childers  |  October 18, 2019

A patient with rheumatoid arthritis (RA) asks if diet can help ease their symptoms. Or maybe a patient with severe knee osteoarthritis (OA) seeks diet advice because they want to lose weight and relieve pressure on their joints. Although there’s no specific nutrition plan for patients with rheumatic diseases, research has shown many dietary factors…

Filed under:Practice Support Tagged with:Association of Rheumatology Professionals (ARP)Dietdietitian

Case Report: A Patient Develops Scleroderma Renal Crisis

Adria Madera-Acosta, MD, Teresa Sosenko, MD, & Diana Girnita, MD, PhD  |  October 18, 2019

Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis. SRC occurs in 2–15% of patients with diffuse sclerosis and usually within the first five years from the time of diagnosis. Risk factors for SRC include, but are not limited to, early diagnosis, corticosteroid or cyclosporine use, and the presence of anti-RNA polymerase III…

Filed under:ConditionsSystemic Sclerosis Tagged with:case reportdiffuse systemic sclerosisScleroderma Renal Crisis

  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 93
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences